Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,082 | 4,443 | 3,116 | 4,302 | 5,756 |
| Other current assets | 101 | 0 | 0 | 0 | 0 |
| TOTAL | $3,353 | $4,749 | $3,572 | $4,899 | $6,568 |
| Non-Current Assets | |||||
| PPE Net | 1,394 | 1,477 | 1,495 | 1,514 | 1,535 |
| Other Non-Current Assets | 143 | 178 | 211 | 245 | 251 |
| TOTAL | $1,537 | $1,655 | $1,706 | $1,759 | $1,786 |
| Total Assets | $4,890 | $6,403 | $5,278 | $6,657 | $8,353 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 161 | 109 | 520 | 145 | 317 |
| Accrued Expenses | 888 | 832 | 697 | 552 | 621 |
| TOTAL | $1,149 | $1,041 | $1,317 | $810 | $1,049 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 49 | 72 | 95 | 118 | 140 |
| TOTAL | $49 | $72 | $95 | $118 | $140 |
| Total Liabilities | $1,198 | $1,113 | $1,412 | $928 | $1,189 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,814 | 1,494 | 1,494 | 554 | 538 |
| Common Shares | 0 | 0 | 0 | 0 | 2 |
| Retained earnings | -40,088 | -38,490 | -36,533 | -34,669 | -33,237 |
| TOTAL | $3,693 | $5,290 | $3,866 | $5,730 | $7,164 |
| Total Liabilities And Equity | $4,890 | $6,403 | $5,278 | $6,657 | $8,353 |